India Pesticides Q2 FY26 Earnings Call Transcript
India Pesticides Limited's Q2 FY26 earnings call transcript highlights a 26% revenue increase, strong export growth, and plans for expansion and backward integration. The company is on track to achieve ₹1,000 crore revenue for the year.
The announcement provides insights into the company's financial performance and future strategies, which can influence investor decisions and market perception.
The transcript reflects strong financial performance, positive growth outlook, and strategic initiatives for future expansion, indicating a positive sentiment.
* India Pesticides Limited (IPL) held an earnings conference call on November 13, 2025, to discuss the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. * Management guided for revenue of around ₹1,000 crore for the year, with ₹565 crore already achieved in H1 FY26. * They are on track, supported by recovery in key export and domestic markets. * H1 FY26 revenue grew 26% year-on-year. EBITDA for the half-year stood at ₹108 crore, up by 53% with margins at 18.6%. PAT grew 48% to ₹67 crore. * The company remains debt-free, funding growth through internal accruals. * Export sales nearly doubled to ₹140 crore, while domestic revenue remained at ₹150 crore. * Formulation capacity has increased to 10,000 metric tons. * Board approved a backward integration project at Sandila for producing 4,000 metric tons of 2,6-DEA. * Shalvis is expected to contribute around ₹100 crore in revenue next year. * IPL is working towards scaling to a revenue of ₹3,000 crore by 2030. * D.K. Jain mentioned that the global agrochemical sector is showing early signs of recovery. * S.P. Gupta mentioned that the capital expenditure of ₹52 crore has been planned in IPL and ₹64 crore in their 100% subsidiary and both are progressing as per schedule. * Concall discussed the company's financial performance, growth strategy, and market outlook.
What to do with a filing like this
India Pesticides Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by India Pesticides Limited. Read the original for the full detail.